Andreas Woerner

739 total citations
27 papers, 377 citations indexed

About

Andreas Woerner is a scholar working on Hematology, Rheumatology and Surgery. According to data from OpenAlex, Andreas Woerner has authored 27 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 7 papers in Rheumatology and 6 papers in Surgery. Recurrent topics in Andreas Woerner's work include Autoimmune and Inflammatory Disorders Research (15 papers), Adolescent and Pediatric Healthcare (5 papers) and Kawasaki Disease and Coronary Complications (4 papers). Andreas Woerner is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (15 papers), Adolescent and Pediatric Healthcare (5 papers) and Kawasaki Disease and Coronary Complications (4 papers). Andreas Woerner collaborates with scholars based in Switzerland, United States and France. Andreas Woerner's co-authors include Michaël Hofer, Mathias Nelle, Éric Giannoni, Rolf Graf, Matteo Fontana, Carine Wouters, Thierry Roger, Luregn J. Schlapbach, Martin Stocker and Thomas M. Berger and has published in prestigious journals such as Frontiers in Immunology, Annals of the Rheumatic Diseases and Intensive Care Medicine.

In The Last Decade

Andreas Woerner

26 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Woerner Switzerland 11 208 121 90 85 72 27 377
Daniel Clemente Spain 10 74 0.4× 53 0.4× 162 1.8× 89 1.0× 53 0.7× 39 374
Priyankar Pal India 11 161 0.8× 84 0.7× 177 2.0× 55 0.6× 63 0.9× 53 395
Tova Ronis United States 8 80 0.4× 56 0.5× 56 0.6× 80 0.9× 42 0.6× 18 263
Sylvie Nathanson France 12 117 0.6× 230 1.9× 25 0.3× 11 0.1× 42 0.6× 32 532
Janice B. Heikenen United States 11 76 0.4× 127 1.0× 398 4.4× 79 0.9× 86 1.2× 17 886
Alfonso Martínez United States 5 44 0.2× 113 0.9× 202 2.2× 75 0.9× 63 0.9× 10 612
Dirk Föll Germany 7 112 0.5× 64 0.5× 24 0.3× 43 0.5× 22 0.3× 12 248
JT Boyle United States 3 97 0.5× 124 1.0× 271 3.0× 143 1.7× 78 1.1× 4 832
Meryem Albayrak Türkiye 12 125 0.6× 56 0.5× 19 0.2× 18 0.2× 59 0.8× 34 340
Robert H. Judd United States 8 36 0.2× 61 0.5× 329 3.7× 52 0.6× 66 0.9× 10 605

Countries citing papers authored by Andreas Woerner

Since Specialization
Citations

This map shows the geographic impact of Andreas Woerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Woerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Woerner more than expected).

Fields of papers citing papers by Andreas Woerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Woerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Woerner. The network helps show where Andreas Woerner may publish in the future.

Co-authorship network of co-authors of Andreas Woerner

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Woerner. A scholar is included among the top collaborators of Andreas Woerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Woerner. Andreas Woerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Welzel, Tatjana, Andrew Atkinson, Gilbert Koch, et al.. (2025). Influence of Disease Type and Activity on Adalimumab Exposure in Children with Inflammatory Rheumatic Diseases. The Journal of Clinical Pharmacology. 65(10). 1234–1245.
2.
Welzel, Tatjana, Andrew Atkinson, Verena Gotta, et al.. (2024). Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases. Pediatric Rheumatology. 22(1). 5–5. 3 indexed citations
3.
Welzel, Tatjana, Jasmin Kuemmerle‐Deschner, Constantin Sluka, et al.. (2022). Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland. Frontiers in Pediatrics. 10. 993811–993811. 4 indexed citations
4.
Koechlin, Helen, et al.. (2022). Estimating the prevalence of paediatric chronic pain in Switzerland: an online survey among paediatricians. Swiss Medical Weekly. 152(2324). w30194–w30194. 3 indexed citations
5.
6.
7.
Prader, Seraina, Nicole Ritz, Frédéric Baleydier, et al.. (2021). X-Linked Lymphoproliferative Disease Mimicking Multisystem Inflammatory Syndrome in Children—A Case Report. Frontiers in Pediatrics. 9. 691024–691024. 3 indexed citations
8.
Vinit, Caroline, Sophie Georgin‐Lavialle, Alexandre Bélot, et al.. (2021). Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review. Frontiers in Immunology. 12. 744780–744780. 4 indexed citations
9.
Dumaine, Cécile, Alexandre Bélot, Salma Malik, et al.. (2019). Infectious adverse events in children with Juvenile Idiopathic Arthritis treated with Biological Agents in a real-life setting: Data from the JIRcohorte. Joint Bone Spine. 87(1). 49–55. 17 indexed citations
10.
Panozzo, Catherine A., et al.. (2018). Arthritis and arthralgia as an adverse event following immunization: A systematic literature review. Vaccine. 37(2). 372–383. 9 indexed citations
11.
Woerner, Andreas, Farshad Pourmalek, Catherine A. Panozzo, et al.. (2018). Acute aseptic arthritis: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 37(2). 384–391. 2 indexed citations
12.
Aeschlimann, Florence A., Walter Baer, Michaël Hofer, et al.. (2016). Clinical course and therapeutic approach to varicella zoster virus infection in children with rheumatic autoimmune diseases under immunosuppression. Pediatric Rheumatology. 14(1). 34–34. 19 indexed citations
13.
Woerner, Andreas, Christoph Rudin, Caterina Bonetto, et al.. (2016). IgA vasculitis (Henoch–Schönlein): Case definition andguidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 35(11). 1559–1566. 8 indexed citations
14.
Woerner, Andreas, Annette von Scheven-Gête, Rolando Cimaz, & Michaël Hofer. (2015). Complications of systemic juvenile idiopathic arthritis: risk factors and management recommendations. Expert Review of Clinical Immunology. 11(5). 575–588. 20 indexed citations
15.
Woerner, Andreas, Florence Uettwiller, Isabelle Melki, et al.. (2015). Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agent. RMD Open. 1(1). e000036–e000036. 36 indexed citations
16.
Woerner, Andreas & Nicole Ritz. (2013). Infections in Children Treated With Biological Agents. The Pediatric Infectious Disease Journal. 32(3). 284–288. 10 indexed citations
17.
Schlapbach, Luregn J., Rolf Graf, Andreas Woerner, et al.. (2013). Pancreatic stone protein as a novel marker for neonatal sepsis. Intensive Care Medicine. 39(4). 754–763. 51 indexed citations
18.
Schlapbach, Luregn J., Andreas Woerner, Steffen Thiel, et al.. (2012). Good agreement between capillary and venous sampling for lectin pathway proteins. Immunobiology. 218(4). 465–469. 2 indexed citations
19.
Woerner, Andreas, et al.. (2011). Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-α inhibitors. Human Vaccines. 7(12). 1293–1298. 11 indexed citations
20.
Woerner, Andreas, et al.. (2008). Neonatological and pulmonological management of bilateral pulmonary sequestration in a neonate. World Journal of Pediatrics. 4(4). 301–304. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Clemente Breakdown of academic impact, for papers by Priyankar Pal Breakdown of academic impact, for papers by Tova Ronis Breakdown of academic impact, for papers by Sylvie Nathanson Breakdown of academic impact, for papers by Janice B. Heikenen Breakdown of academic impact, for papers by Alfonso Martínez Breakdown of academic impact, for papers by Dirk Föll Breakdown of academic impact, for papers by JT Boyle Breakdown of academic impact, for papers by Meryem Albayrak Breakdown of academic impact, for papers by Robert H. Judd
Rankless by CCL
2026